Sanofi to Acquire Dynavax, Expanding Adult Vaccine Pipeline
Paris, France | December 24, 2025 — Sanofi announced that it has entered into a definitive agreement to acquire...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mergers & Acquisitions for New Therapy
Paris, France | December 24, 2025 — Sanofi announced that it has entered into a definitive agreement to acquire...
Boucherville, Quebec | December 23, 2025 — LSL Pharma Group Inc., a Canadian integrated pharmaceutical company, announced the successful...
United States | December 23, 2025 — Fulgent Genetics has entered into a definitive agreement to acquire specific assets...
INCHEON, South Korea; ROCKVILLE, Maryland; LONDON — December 21, 2025 — Samsung Biologics, a global contract development and manufacturing...
Louvain-La-Neuve, Belgium, December 19, 2025 — IBA (Ion Beam Applications S.A.), a global leader in particle accelerator technology and...
NASHVILLE, Tennessee — December 15, 2025 — Cencora, Inc. announced it has entered into a definitive agreement to acquire...
NEW YORK — December 15, 2025 — SK Capital Partners, LP, a private investment firm focused on life sciences...
BOSTON, December 12, 2025 — Contineum Therapeutics, Inc. announced the pricing of an upsized $90.0 million public offering of...
COPENHAGEN, Denmark – December 12, 2025 — Genmab has completed its tender offer to acquire outstanding common shares of...
Bagsværd, Denmark & South San Francisco, CA — December 9, 2025 — Novo Nordisk has officially completed its acquisition...
